RxDoctor Payments Data

Joseph Eder

Hematology & Oncology · Boston, MANPI 1043233497

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,600 of the $9,576 with a category attached, or 68.9%. Roche Molecular Systems, Inc. accounts for 68.9% of it on its own, with 2 other manufacturers making up the rest.

$9,576in general payments, 2019–2025

Across 9 payments — averaging $1064.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Molecular Systems, Inc.$7K
  • F. Hoffmann-la Roche AG$3K
  • AstraZeneca$11
$2,246,756in research payments, 2019–2025

Across 146 payments — averaging $15,389 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$879K
  • Genentech, Inc.$608K
  • Sanofi US Services Inc.$231K
  • Merck$186K
  • E.r. Squibb & Sons, L.L.C.$174K
  • Roche Products Limited$91K
  • plus $78K from 4 others

What the payments were for

  • Consulting fees$6,60069%
  • Speaking & faculty fees$2,96531%
  • Food & beverage$110%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,576 in reported general payments places this provider in the 70th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Other hematology & oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →